Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Colorcon
Baxter
Citi
Boehringer Ingelheim
Johnson and Johnson
US Army
Federal Trade Commission
Argus Health

Generated: November 19, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Obinutuzumab

« Back to Dashboard

US Patents for Obinutuzumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Obinutuzumab ➤ Try a Free Trial Antibody targeting cell surface deposited complement protein C3d and use thereof The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) University of Virginia Patent Foundation (Charlottesville, VA) ➤ Try a Free Trial
Obinutuzumab ➤ Try a Free Trial Salts and solid form of a BTK inhibitor PRINCIPIA BIOPHARMA INC. (South San Francisco, CA) ➤ Try a Free Trial
Obinutuzumab ➤ Try a Free Trial Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality Genentech, Inc. (South San Francisco, CA) ➤ Try a Free Trial
Obinutuzumab ➤ Try a Free Trial Antibody-SN-38 immunoconjugates with a CL2A linker Immunomedics, Inc. (Morris Plains, NJ) ➤ Try a Free Trial
Obinutuzumab ➤ Try a Free Trial Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients Corning Incorporated (Corning, NY) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Obinutuzumab

Drugname Country Document Number Estimated Expiration Related US Patent
Obinutuzumab Canada 2936346 2034-01-08 ➤ Try a Free Trial
Obinutuzumab European Patent Office 3092252 2034-01-08 ➤ Try a Free Trial
Obinutuzumab World Intellectual Property Organization (WIPO) 2015105973 2034-01-08 ➤ Try a Free Trial
Obinutuzumab Canada 2929918 2033-12-05 ➤ Try a Free Trial
Obinutuzumab China 105793251 2033-12-05 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Farmers Insurance
Cantor Fitzgerald
AstraZeneca
Covington
Mallinckrodt
Johnson and Johnson
US Department of Justice
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.